MARKET

NVUS

NVUS

Novus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6600
-0.0062
-0.93%
Closed 16:00 11/20 EST
OPEN
0.6700
PREV CLOSE
0.6662
HIGH
0.6800
LOW
0.6501
VOLUME
19.64K
TURNOVER
--
52 WEEK HIGH
5.21
52 WEEK LOW
0.4000
MARKET CAP
8.56M
P/E (TTM)
-0.3832
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NVUS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NVUS News

  • Novus Therapeutics EPS beats by $0.19
  • seekingalpha.11/13 17:35
  • Novus Therapeutics Q3 EPS $(0.22) Up From $(0.37) YoY
  • Benzinga.11/13 12:38
  • Novus Therapeutics Reports Third Quarter 2019 Financial Results
  • Business Wire.11/13 12:30
  • Novus Therapeutics Reports Receives FDA Guidance On OP0201 Phase 2a Study
  • Benzinga.10/29 11:34

More

Industry

Pharmaceuticals
-0.37%
Pharmaceuticals & Medical Research
-0.14%

Hot Stocks

Name
Price
%Change

About NVUS

Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-01 is currently being developed as an improved treatment option for acute otitis externa. OP-02 is a daily nasal spray that is designed to improve and maintain a healthy middle ear. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction. OP-02 is a combination drug product, which comprises two components: surfactant dipalmitoylphosphatidylcholine and a spreading agent cholesteryl palmitate. The product is sprayed through the nostrils toward the opening of the Eustachian tube at the back of the nasal cavity.
More

Webull offers Novus Therapeutics Inc (NVUS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.